深圳市亚辉龙生物科技股份有限公司关于召开2025年第三季度业绩说明会的公告

Core Viewpoint - Shenzhen YHLO Biotech Co., Ltd. is set to hold a Q3 2025 earnings presentation on December 3, 2025, to discuss its operational results and financial indicators, inviting investors to submit questions in advance [2][3][4]. Group 1: Earnings Presentation Details - The earnings presentation will take place on December 3, 2025, from 15:00 to 16:00 at the Shanghai Stock Exchange Roadshow Center [2][6]. - Investors can participate online through the Shanghai Stock Exchange Roadshow Center and are encouraged to submit questions from November 26 to December 2, 2025 [5][6]. - Key company personnel, including the Chairman and CFO, will be present to address investor inquiries [4]. Group 2: Medical Device Registration - The company has recently received a medical device registration certificate from the Guangdong Provincial Drug Administration for the ST2 protein test, which is significant for cardiovascular disease detection [7][8]. - The ST2 protein is linked to heart function and can predict outcomes in acute myocardial infarction (AMI) patients, enhancing the company's product offerings in the cardiovascular diagnostics sector [8][9]. - The newly registered iMegaFlow analyzer is a semi-automated device designed for quantitative or semi-quantitative analysis of human samples, featuring a compact design and ease of use [9].